CBIO
Crescent Biopharma
CBIO
CBIO
36 hedge funds and large institutions have $3M invested in Crescent Biopharma in 2024 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 12 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
67% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 12
Holders
36
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$23.7K | |
| 2 | +$16.9K | |
| 3 | +$14K | |
| 4 |
Two Sigma Investments
New York
|
+$7.54K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$5.75K |
Top Sellers
| 1 | -$2.42M | |
| 2 | -$227K | |
| 3 | -$29.3K | |
| 4 |
Millennium Management
New York
|
-$28.2K |
| 5 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
-$28.2K |